Digibus (c): results from the first self-driving shuttle trial on a public road in Austria

被引:33
|
作者
Rehrl, Karl [1 ]
Zankl, Cornelia [1 ]
机构
[1] Salzburg Res Forsch Gesellsch mbH, Jakob Haringer Str 5, A-5020 Salzburg, Austria
关键词
Automated driving; Self-driving shuttle; Public road trial; Rural area; First/last mile;
D O I
10.1186/s12544-018-0326-4
中图分类号
U [交通运输];
学科分类号
08 ; 0823 ;
摘要
From April to November 2017, the non-profit research organisation Salzburg Research conducted the "Digibus (c) 2017" trial, the first trial of a self-driving shuttle on a public road in Austria. The shuttle from the French company Navya Tech has been tested on a 1.4-km long track in the village of Koppl, which is situated approximately ten kilometres east from the City of Salzburg. The trial in Koppl was one of the first trials worldwide on public roads with mixed traffic in a rural area. The focus of this trial was on the real-world evaluation of a self-driving shuttle for bridging the first/last mile in public transport. From April to November 2017, 240 test drives with 874 passengers covering 341 test kilometres have been conducted. Results show that the technology is ready for testing, but there is still a long way to go for driverless operation, especially in mixed traffic scenarios. The work describes the trial setting, the test route, the process of deploying the shuttle, experiences collected during the trial as well as results from a passenger survey. The accompanying passenger survey with 294 participants revealed high acceptance and a good feeling of safety.
引用
收藏
页数:11
相关论文
共 45 条
  • [21] Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: Results from the BICC-C study
    Fuchs, Charles S.
    Marshall, John
    Mitchell, Edith
    Wierzbicki, Rafal
    Ganju, Vinod
    Jeffery, Mark
    Schulz, Joseph
    Richards, Donald
    Soufi-Mahjoubi, Raoudha
    Wang, Benjamin
    Barrueco, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4779 - 4786
  • [22] Subjective well-being under neuroleptic treatment with olanzapine versus clozapine:: First results from a double-blind clinical trial using the SWN self-rating scale
    Naber, D
    Bandelow, B
    Bender, S
    Klimke, A
    Kühn, K
    Lambert, M
    Lemmer, W
    Riedel, M
    Vorbach, E
    Dittmann, RW
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 240 - 240
  • [23] Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first- line treatment of metastatic colorectal cancer: Updated results from the BICC-C study
    Fuchs, Charles S.
    Marshall, John
    Barrueco, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 689 - 690
  • [24] HIV self-testing intervention experiences and kit usability: results from a qualitative study among men who have sex with men in the SELHPI (Self-Testing Public Health Intervention) randomized controlled trial in England and Wales
    Witzel, T. C.
    Bourne, A.
    Burns, F. M.
    Rodger, A. J.
    McCabe, L.
    Gabriel, M. M.
    Gafos, M.
    Ward, D.
    Collaco-Moraes, Y.
    Dunn, D. T.
    Speakman, A.
    Bonell, C.
    Pebody, R.
    Lampe, F. C.
    Harbottle, J.
    Phillips, A. N.
    McCormack, S.
    Weatherburn, P.
    HIV MEDICINE, 2020, 21 (03) : 189 - 197
  • [25] Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD plus C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS
    Houot, R.
    Le Gouill, S.
    Uribe, M. Ojeda
    Mounier, C.
    Courby, S.
    Dartigeas, C.
    Bouabdallah, K.
    Vigier, M. Alexis
    Moles, M. P.
    Tournilhac, O.
    Arakelyan, N.
    Rodon, P.
    El Yamani, A.
    Sutton, L.
    Fornecker, L.
    Assouline, D.
    Harousseau, J. L.
    Maisonneuve, H.
    Caulet-Maugendre, S.
    Gressin, R.
    ANNALS OF ONCOLOGY, 2012, 23 (06) : 1555 - 1561
  • [26] A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: Results From the Multi-Center Randomized Controlled PATENT-C First in Human Trial
    Scheller, Bruno
    Fontaine, Tobias
    Mangner, Norman
    Hoffmann, Stefan
    Bonaventura, Klaus
    Clever, Yvonne P.
    Chamie, Daniel
    Costa, Ribamar
    Gershony, Gary
    Kelsch, Bettina
    Kutschera, Maren
    Genereux, Philippe
    Cremers, Bodo
    Boehm, Michael
    Speck, Ulrich
    Abizaid, Alexandre
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 88 (01) : 51 - 59
  • [27] A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: Two Years Follow-up Results from the PATENT-C First in Human Trial
    Scheller, Bruno
    Chamie, Daniel
    Mangner, Norman
    Hoffmann, Stefan
    Bonaventura, Klaus
    Clever, Yvonne P.
    Fontaine, Tobias
    Costa, Jose D., Jr.
    Gershony, Gary
    Kelsch, Bettina
    Kutschera, Maren
    Genereux, Philippe
    Cremers, Bodo
    Speck, Ulrich
    Abizaid, Alexandre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B168 - B168
  • [28] FIRST-IN-CLASS NAE INHIBITOR MLN4924 IN COMBINATION WITH AZACITIDINE FOR ACUTE MYELOID LEUKEMIA (AML) PATIENTS CONSIDERED UNFIT FOR CONVENTIONAL CHEMOTHERAPY: RESULTS FROM THE C15009 TRIAL
    Swords, R. T.
    Savona, M. R.
    Maris, M. B.
    Erba, H. P.
    Hua, Z.
    Faessel, H.
    Blakemore, S. J.
    Sedarati, F.
    Dezube, B. J.
    Medeiros, B. C.
    HAEMATOLOGICA, 2014, 99 : 223 - 224
  • [29] Reduced Intensity Conditioning transplantation (RIC) as part of first line therapy for Mantle cell lymphoma: results from the Phase II Mini Allo trial (CRUK: C7627/A9080)
    Peggs, K.
    Cook, G.
    Russell, N.
    Hunter, A.
    Robinson, S.
    Morley, N.
    Sureda, A.
    Smith, P.
    Patrick, P.
    Braganca, N.
    Stevens, L.
    Adedayo, T.
    Kirkwood, A.
    Rule, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S69 - S69
  • [30] REDUCED INTENSITY CONDITIONING TRANSPLANTATION (RIC) AS PART OF FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: RESULTS FROM THE PHASE II MINI ALLO TRIAL (CRUK: C7627/A9080)
    Rule, S.
    Peggs, K.
    Russell, N.
    Cook, G.
    Hunter, A.
    Morley, N.
    Sureda, A.
    Smith, P.
    Patrick, P.
    Braganca, N.
    Stevens, L.
    Adedayo, T.
    Kirkwood, A.
    Robinson, S.
    HAEMATOLOGICA, 2016, 101 : 110 - 110